CTNM

NASDAQ:CTNM

Contineum Therapeutics

  • Stock

USD

Last Close

11.01

06/11 21:00

Market Cap

541.73M

Beta: -

Volume Today

132.52K

Avg: -

PE Ratio

−20.64

PFCF: −17.65

OverviewFinancialsAPI
Income StatementBalance SheetCash FlowKey MetricsRatios
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '21
Dec '22
Dec '23
average inventory
average payables
545K
-
532.50K
2.29%
average receivables
book value per share
-4.25
-
-3.71
12.76%
-4.07
9.85%
capex per share
0.01
-
0.00
53.40%
0.02
428.79%
capex to depreciation
0.52
-
0.36
30.62%
2.12
491.94%
capex to operating cash flow
-0.01
-
-0.01
8.31%
0.02
464.85%
capex to revenue
0.01
-
cash per share
4.14
-
1.88
54.58%
7.51
299.42%
days of inventory on hand
days payables outstanding
477.05
-
days sales outstanding
debt to assets
0.07
-
2.69
3,770.41%
1.48
45.17%
debt to equity
-0.07
-
-1.46
2,013.75%
-2.84
93.72%
dividend yield
earnings yield
-0.11
-
-0.06
44.51%
0.09
241.19%
enterprise value
257.06M
-
519.78M
102.20%
434.45M
16.42%
enterprise value over ebitda
-9.07
-
-22.08
143.44%
18.43
183.45%
ev to operating cash flow
-9.79
-
-25.83
163.95%
22.45
186.92%
ev to sales
8.69
-
free cash flow per share
-1.59
-
-0.81
49.20%
1.14
241.01%
free cash flow yield
-0.10
-
-0.05
49.20%
0.07
241.01%
graham net net
-4.34
-
-3.84
11.47%
-4.39
14.09%
graham number
12.90
-
8.97
30.43%
11.18
24.54%
income quality
0.91
-
0.83
8.40%
0.85
2.65%
intangibles to total assets
0
-
0
0
interest coverage
-86.29
-
-58.56
32.14%
77.29
232.00%
interest debt per share
0.31
-
5.44
1,632.07%
11.56
112.42%
inventory turnover
invested capital
66.75M
-
42.96M
35.64%
123.62M
187.77%
market cap
256.78M
-
387.01M
50.72%
256.78M
33.65%
net current asset value
-71.63M
-
-95.46M
33.26%
-70.62M
26.02%
net debt to ebitda
-0.01
-
-5.64
57,189.56%
7.54
233.61%
net income per share
-1.74
-
-0.97
44.51%
1.36
241.19%
operating cash flow per share
-1.58
-
-0.80
49.17%
1.16
244.93%
payables turnover
0.77
-
receivables turnover
research and ddevelopement to revenue
0.55
-
return on tangible assets
-0.41
-
-0.48
16.46%
0.17
136.38%
revenue per share
3.00
-
roe
0.41
-
0.26
36.40%
-0.33
228.53%
roic
0.44
-
-0.53
220.09%
0.13
124.05%
sales general and administrative to revenue
0.13
-
shareholders equity per share
-4.25
-
-3.71
12.76%
-4.07
9.85%
stock based compensation to revenue
0.04
-
tangible asset value
-70.89M
-
-93.21M
31.48%
-67.94M
27.12%
tangible book value per share
-4.25
-
-3.71
12.76%
-4.07
9.85%
working capital
66.11M
-
40.84M
38.22%
122.22M
199.26%

All numbers in USD (except ratios and percentages)